Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21131
Title: Use of a Silicon Stoma Stent as an Interim Step in High-Risk Tracheostomy Decannulation.
Authors: Ross, Jacqueline M;McMurray, Kristy;Cameron, Tanis;Lanteri, Celia
Affiliation: Victorian Spinal Cord Service, Austin Health, Heidelberg, Victoria, Australia
Ventilator Accommodation Support Service, Melbourne, Australia
Australian Nursing Federation, Melbourne, Australia
Department of Respiratory Medicine, Austin Health, Melbourne, Australia
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Tracheostomy Review and Management Service, Austin Health, Heidelberg, Victoria, Australia
Department of Speech Pathology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: Mar-2019
EDate: 2019-03-22
Citation: OTO open 2019; 3(1): 2473974X19836432
Abstract: To describe use of a stoma stent to facilitate high-risk decannulation. Retrospective chart review of 14 consecutive patients who received a stent from March 2013 to December 2016 at a quaternary health care service. Primary outcome measures were decannulation outcome and adverse events. Decannulation outcome: 12 of 14 patients had their tracheostomy tube (TT) removal facilitated by stent use. Patients had the stent for a median of 6 days (interquartile range, 49). Reasons for use included medical instability, risk of sputum retention, uncertain airway patency, and the need for ongoing airway access. All patients survived to discharge. One patient residing in the community has retained a stoma stent. Adverse events: One patient removed the stent on the day of insertion, necessitating reinsertion of the TT. Granulation tissue at the stoma site was seen in 2 patients. A tracheostoma will normally close within 48 hours following decannulation, which is problematic if TT reinsertion is required. By using the stent, reversal of decannulation becomes a simple ward-based procedure. In comparison to a TT, which is secured with ties, the stoma stent proved unsuitable for use in an agitated patient. Decreasing total cannulation time is of benefit as patients with tracheostomy are subject to high rates of complications and adverse events. A stoma stent poses little risk and a low morbidity burden to the patient in comparison to alternative management.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21131
DOI: 10.1177/2473974X19836432
ORCID: 0000-0002-2562-1829
PubMed URL: 31236540
Type: Journal Article
Subjects: Montgomery cannula
decannulation
patient safety/quality initiative (PS/QI)
tracheostomy
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.